InvestorsHub Logo
Followers 10
Posts 504
Boards Moderated 0
Alias Born 04/20/2016

Re: None

Monday, 02/27/2017 9:48:45 PM

Monday, February 27, 2017 9:48:45 PM

Post# of 869
Next catalyst Phase I results for encochleated amakacin.

Per the company, these results will be announced in 1Q 2017, i.e., within the next 30 days.

The next catalyst after that will be the results of two Phase II studies of encochleated amphotericin B that, per the company, will be announced in 1H 2017.

These are very exciting times for the company and its shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTNB News